SurModics to Present at Jefferies Healthcare Conference
June 01 2016 - 8:05AM
Business Wire
Webcast is Live on Tuesday, June 7, at 4 p.m.
(ET)
SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical
device and in vitro diagnostic technologies, today announced that
Gary Maharaj, president and chief executive officer, and Andy
LaFrence, vice president of finance and chief financial officer,
will make a presentation to the investment community at the
Jefferies Healthcare Conference in New York City on Tuesday,
June 7, 2016, at 4 p.m. ET (3 p.m. CT).
A live audio webcast of the presentation will be available by
going to the investor relations portion of the Company’s website at
www.surmodics.com and clicking on the webcast icon. The webcast
will be archived on the Company’s website for 90 days
following the meeting.
About SurModics, Inc.SurModics is the global leader in
surface modification technologies for intravascular medical devices
and a leading provider of chemical components for in vitro
diagnostic (IVD) tests and microarrays. Following two recent
acquisitions of Creagh Medical and NorMedix, the Company is
executing a key growth strategy for its medical device business by
expanding to offer total intravascular product solutions to its
medical device customers. The combination of proprietary surface
technologies, along with enhanced device design, development and
manufacturing capabilities, enables SurModics to significantly
increase the value it offers with highly differentiated
intravascular solutions designed and engineered to the most
demanding requirements. With this focus on offering total
solutions, SurModics’ mission remains to improve the detection and
treatment of disease by using our technology to provide solutions
to difficult medical device and diagnostic challenges. SurModics is
headquartered in Eden Prairie, Minnesota. For more information
about the company, visit www.surmodics.com. The content of
SurModics’ website is not part of this press release or part of any
filings that the company makes with the SEC.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160601005466/en/
SurModics, Inc.Andy LaFrence, 952-500-7000ir@surmodics.com
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Apr 2023 to Apr 2024